IgG Seroprevalence of COVID-19 among Individuals without a History of the Coronavirus Disease Infection in Daegu, Korea

Abstract

Background: Seroprevalence studies of coronavirus disease 2019 (COVID-19) from many countries have shown that the number of undiagnosed missing cases is much larger than that of confirmed cases, irrespective of seroprevalence levels. Considering the strategy of Korea entailing massive testing and contact tracing from the beginning of epidemic, the number of undiagnosed missing cases in Korea may be negligible. This study was conducted to estimate the seroprevalence of COVID-19 among individuals who were never diagnosed with COVID-19 in Daegu, the epicenter of COVID-19 epidemic in Korea. Methods: Serologic testing for immunoglobulin G antibody based on immunochromatographic assay was conducted in 103 patients and 95 guardians aged 18 to 82 years without any history of COVID-19 diagnosis, who visited outpatient clinics of a single university-affiliated hospital from May 25 to June 5, 2020. Results: The estimated seroprevalence was 7.6% (95% confidence interval, 4.3%-12.2%) with 15 positive cases. Among them, only one had a polymerase chain reaction (PCR)-confirmed case among their close contacts and 13 did not experience COVID-19-related symptoms. Seroprevalence was similar between patients and guardians. Based on this figure, the number of undiagnosed missing cases in Daegu was estimated to be a dozen times more than the number of confirmed cases based on PCR testing. Conclusion: Despite the limitation of a small and unrepresentative sample, this is the first study on seroprevalence of COVID-19 in Korea. Our study suggested that the number of undiagnosed missing cases was substantial even with the stringent strategy adopted in Korea, similar to that of other countries.

Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign

“…Indeed, it was suggested that SARS-CoV-2 affected women less compared with men, due to different innate immunity, steroid hormones, and factors related to sex chromosomes ( 14 ). However, this female over male trend in asymptomatic carriers was not captured in other areas and countries, such as South Korea, Thailand, Iran, Spain, and California of USA ( 15 , 16 , 17 , 18 ). Whether this trend is observed only in Wuhan or can be observed in other parts of China or other countries too needs further investigation.…”

Assessing the Age Specificity of Infection Fatality Rates for COVID-19: Systematic Review, Meta-Analysis, and Public Policy Implications

“…We identify such countries using a threshold of 300 for the ratio of cumulative tests to reported cases as of 30 April 2020, based on comparisons of prevalence estimates and reported cases in Czech Republic, Korea, and Iceland; see Supplementary Appendices D and E. [17] Studies of Iceland and Korea found that estimated prevalence was moderately higher than the number of reported cases, especially for younger age groups; hence we make corresponding adjustments for other countries with comprehensive tracing programs, and we identify these estimates as subject to an elevated risk of bias. [18][19][20]…”

Seroprevalence of Anti-SARS-CoV-2 Antibodies among Outpatients in Southwestern Seoul, Korea

“…In Korea, seroprevalence of antibodies to SARS-CoV-2 among 198 outpatients and their guardians was 7.6% in Daegu in which more than half (56.9%, 6,881/12,088) of domestic cases with COVID-19 occurred as of August 11, 2020. 18 However, because of the heterogeneous and inconsistent results, the clinical performance of SARS-CoV-2 rapid lateral flow assay is still under evaluation, requiring confirmatory testing such as neutralization assay. 19 Considering the possible cross-reactivity from the pre-existing common cold coronaviruses (NL63, 229E, OC43 or HKU1) antibodies, it is necessary to be careful in interpreting the results.…”